ToothWave Plaque and Gingivitis Study

Home Skinovations Ltd.86 enrolled

Overview

The objective of the study is to evaluate the safety and efficacy of the home-use device Silk'n toothbrush (ToothWave) for the improvement in dental health through the reduction of plaque, gingivitis, and calculus.

This is a single blind, prospective study aimed to evaluate the safety and efficacy of the Silk'n toothbrush in reduction of gingivitis, dental plaque and calculus. The study includes 84 treatment sessions, twice a day, and 4 clinic visits over a period of 6 weeks. One treatment group (Silk'n toothbrush - ToothWave) and 1 control group (an ADA approved power toothbrush (PTB)) will participate in the study. For each patient, assessment data will be collected at baseline, 4 weeks, and at 6 weeks. The average data sets will be calculated for each group. Treatment is defined as a timed 2 minutes of teeth brushing in a regular man-ner, twice a day (morning and evening). Brushing will be undertaken using the Silk'n toothbrush and standard fluoride toothpaste. The control group will use a regular PTB and standard fluoride toothpaste.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

Conditions

Gingivitis Plaque Calculus, Dental

Interventions

RF utilizing powered toothbrushDEVICE

RF utilizing Powered toothbrush

Control placebo with no RFDEVICE

Placebo control, with no RF

Eligibility

Sex: ALLMin age: 18 YearsMax age: 70 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: 1. Adult subjects aged 18-70, that are in good health. 2. Subject must have: 2.2. Baseline gingivitis (MGI) score of at least 1.80, 2.3. Dental Plaque mean score greater than 0.6 according to the RMNPI Index. 2.4. Total Calculus deposits greater than 7 according to the Volpe-Manhold Index. 3. Have a minimum of 20 'scorable' teeth (excluding 3rd molars). 4. The subjects should understand the information provided about the investigative nature of the treatment, possible benefits and side effects. Subjects will sign the Informed Consent Form. 5. The subjects should be willing to comply with the study procedure and schedule, including the follow up visits. Exclusion Criteria: 1. Current or history of oral cavity cancer or oropharyngeal cancer. 2. Pacemaker or internal defibrillator, or any other active electrical implant anywhere in the body. 3. Pregnant or nursing by subject report. 4. Any active condition in the oral cavity at the discretion of the investigator. 5. Any surgery in the oral cavity within 3 months prior to treatment, or before complete healing. 6. Subjects that do not brush regularly. 7. Any condition that might make it unsafe for the subject to participate in this study, at the discretion of the investigator.

Locations (1)

Salus research

Fort Wayne, Indiana, United States

Outcomes

Primary Outcomes

Dental plaque

A reduction in the level of dental plaque according to Rustogi Modification of the Navy Plaque Index (RMNPI).

Time frame: 6 weeks

Gingival inflammation

A reduction in the level of gingival inflammation according to the Modified Gingival Index (MGI).

Time frame: 6 weeks

Secondary Outcomes

Calculus

A reduction of calculus deposits as evaluated by Volpe-Manhold Index

Time frame: 6 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.